| Literature DB >> 31754810 |
Stijn C Voeten1,2, Leti van Bodegom-Vos3, J H Hegeman4, Michel W J M Wouters5,6, Pieta Krijnen7, Inger B Schipper7.
Abstract
To ensure meaningful results in a clinical audit, as many hospitals as possible should participate. To optimise participation, the data collection process should either be performed by additional staff or be automated. Active participation may be promoted by offering relevant external parties insight into the actual quality of care.Entities:
Keywords: Clinical audit; Hip fractures; Implementation science
Mesh:
Year: 2019 PMID: 31754810 PMCID: PMC6872508 DOI: 10.1007/s11657-019-0652-8
Source DB: PubMed Journal: Arch Osteoporos Impact factor: 2.617
What does participation in the DHFA mean at hospital level?
| Subscription | - Hospital participation in the DHFA is not compulsory, but the four medical associations that jointly developed the DHFA dataset advised their members to participate. - A hospital can subscribe to participate, subject to agreement of its executive board. - Participation is free of costs. - There are no financial incentives for participation. |
| Data gathering | - Data from the electronic health record needs to be entered into the Dutch Hip Fracture database. - The DHFA does not provide nationwide staffing or other resources or personal for the data gathering. - It is up to the local hospital to organise the data gathering process and to decide which medical professional(s) is (are) responsible for the data gathering process. - For all hip fracture patients of 18 years or older, 45 items need to be entered into a web-based survey spread at three different moments in the treatment process. - These three different moments are on admission, 3 months after admission and 1 year after admission. - Patients having a pathologic fracture due to a malignant disease or a periprosthetic fracture should not be registered. |
| Advantages | - A weekly updated report to provide insight into the hospital’s own clinical performance on structures, processes and outcomes of hip fracture care - Hospitals’ clinical performances are also benchmarked. This can help hospitals determine how their treatment process can be optimised, and how specific intervention can be implemented to ensure a higher quality of hip fracture care. - All quality indicators, as demanded by the two supervisory government agencies, i.e. the National Health Care Institute and the Health and Youth Care Inspectorate, can be calculated from the DHFA database. This prevents that physicians have to register the same data in multiple databases. |
Characteristics of the 109 respondents divided by participation degree
| Total | Not participating in the DHFA, and not intending to do so | Not participating in the DHFA, but intending to do so | Partially participating in the DHFA, < 80% of patients registered | Actively participating in the DHFA, ≥ 80% of patients registered | |
|---|---|---|---|---|---|
| Type of surgeon | |||||
| Orthopaedic surgeon | 22 (20.2%) | 1 (4.5%) | 11 (50.0%) | 3 (13.6%) | 7 (31.8%) |
| Trauma surgeon | 87 (79.8%) | 5 (5.7%) | 18 (20.7%) | 20 (23.0%) | 44 (50.6%) |
| Years of experience | |||||
| 1–5 years | 16 (14.7%) | 2 (12.5%) | 4 (25.0%) | 1 (6.3%) | 9 (56.3%) |
| 6–10 years | 33 (30.3%) | 1 (3.0%) | 10 (30.3%) | 5 (15.2%) | 17 (51.5%) |
| 11–15 years | 19 (17.4%) | 0 (0.0%) | 6 (31.6%) | 4 (21.1%) | 9 (47.4%) |
| > 15 years | 41 (37.6%) | 3 (7.3%) | 9 (22.0%) | 13 (31.7%) | 16 (39%) |
| Type of hospital | |||||
| Academic hospital | 15 (13.8%) | 2 (13.3%) | 8 (53.3%) | 2 (13.3%) | 3 (20.0%) |
| General hospital | 94 (86.2%) | 4 (4.3%) | 21 (22.3%) | 21 (22.3%) | 48 (51.1%) |
| Annual number of operations | |||||
| 1–20 | 19 (17.4%) | 1 (5.3%) | 10 (52.6%) | 2 (10.5%) | 6 (31.6%) |
| 21–50 | 47 (43.1%) | 2 (4.3%) | 12 (25.5%) | 10 (21.3%) | 23 (48.9%) |
| 51–100 | 32 (29.4%) | 3 (9.4%) | 3 (9.4%) | 9 (28.1%) | 17 (53.1%) |
| > 100 | 11 (10.1%) | 0 (0.0%) | 4 (36.4%) | 2 (18.2%) | 5 (45.5%) |
| Familiar with DHFA | |||||
| Yes | 102 (93.6%) | 2 (2.0%) | 26 (25.5%) | 23 (22.5%) | 51 (50.0%) |
| No | 7 (6.4%) | 4 (57.1%) | 3 (42.9%) | 0 (0.0%) | 0 (0.0%) |
Respondents’ agreement (partly/totally agree (versus partly/totally disagree)) with each factor for participation in the DHFA. The participating group is further stratified by participation degree
| Resondents' agreement with statement among respondents | ||||
|---|---|---|---|---|
| Not participating in the DHFA | Participating in the DHFA | Degree of participation in the DHFA | ||
| < 80% of the patients registered | ≥ 80% of the patients registered | |||
| 1. At hospitals, staffing capacity must be made available for DHFA data collection. | 27 (96.4%) | 70 (94.6%) | 22 (95.7%) | 48 (94.1%) |
| 2. Data entry into the DHFA from the electronic health record should be automated (registry at point of care). | 26 (92.9%) | 71 (95.9%) | 23 (100.0%) | 48 (94.1%) |
| 3. Participation in the DHFA must be supported financially by the hospital board. | 25 (89.3%) | 71 (95.9%) | 22 (95.7%) | 49 (96.1%) |
| 4. Implementation of the DHFA at hospital level requires a plan of action. | 25 (89.3%) | 69 (93.2%) | 21 (91.3%) | 48 (94.1%) |
| 5. The DHFA increases the registration load for physicians. | 27 (96.4%) | 63 (85.1%) | 20 (87.0%) | 43 (84.3%) |
| 6. The DHFA will provide insight into the actual quality of hip fracture care. | 26 (92.9%) | 63 (85.1%) | 18 (78.3%) | 45 (88.2%) |
| 7. To ensure the proper organisation of the DHFA in hospitals, cooperation between the specialist areas involved (surgery, orthopaedics, geriatrics, internal medicine) is essential. | 25 (89.3%) | 65 (87.8%) | 19 (82.6%) | 46 (90.2%) |
| 8. The DHFA is a tool for improving the quality of hip fracture care. | 24 (85.7%) | 62 (83.8%) | 18 (78.3%) | 44 (86.3%) |
| 9. Too much data is requested in the DHFA. | 22 (78.6%) | 64 (86.5%) | 20 (87.0%) | 44 (86.3%) |
| 10. The DHFA must do more than just give online feedback on outcomes. | 23 (82.1%) | 60 (81.1%) | 20 (87.0%) | 40 (78.4%) |
| 11. The DHFA should be linked with other sources (municipal registries, Dutch Arthroplasty Register and Dutch Trauma Registry). | 21 (75.0%) | 64 (86.5%) | 19 (82.6%) | 45 (88.2%) |
| 12. The added value of the DHFA lies in its being initiated and managed by medical practitioners themselves. | 23 (82.1%) | 55 (74.3%) | 17 (73.9%) | 38 (74.5%) |
| 13. I am confident that the DHFA handles data with due care | 21 (75.0%) | 54 (73.0%) | 15 (65.2%) | 39 (76.5%) |
| 14. The 3-month follow-up as required by the DHFA is not part of the standard clinical follow-up. | 18 (64.3%) | 59 (79.7%) | 19 (82.6%) | 40 (78.4%) |
| 15. I am confident that the DHFA working group will make a proper assessment what data (quality indicators) can be made available to external parties. | 19 (67.9%) | 50 (67.7%) | 12 (52.2%) | 38 (74.5%) |
| 16. The division of responsibilities for the execution of the DHFA between the specialists involved is not clear. | 18 (64.3%) | 49 (66.2%) | 16 (69.6%) | 33 (64.7%) |
| 17. For the DHFA, a nationwide registry requirement should be introduced. | 17 (60.7%) | 51 (68.9%) | 13 (56.5%) | 38 (74.5%) |
| 18. Data obtained from the DHFA offers relevant external parties (health insurers, National Health Care Institute) insight into the actual quality of hip fracture care. | 17 (60.7%) | 49 (66.2%) | 11 (47.8%) | 38 (74.5%) |
| 19. The benefits of participation in the DHFA do not outweigh the costs. | 15 (53.6%) | 38 (51.4%) | 15 (65.2%) | 23 (45.1%) |
| 20. The DHFA is going to lead to a cost reduction in hip fracture care. | 14 (50.0%) | 33 (44.6%) | 11 (47.8%) | 22 (43.1%) |
| 21. The added value of the DHFA is not clear. | 11 (39.3%) | 35 (47.3%) | 15 (65.2%) | 20 (39.2%) |
Multivariable logistic regression analysis of participation in the DHFA, including factors with univariable p < 0.10
| Univariable | Multivariable | |
|---|---|---|
| Type of surgeon (orthopaedic vs. trauma surgeon) | 0.39 (0.14–1.12; 0.08) | 0.30 (0.10–0.90; 0.03) |
| Type of hospital (academic vs. general) | 0.18 (0.05–0.62; 0.01) | 0.15 (0.04–0.52; < 0.01) |
| Annual number of operations | ||
| 1–20 | Ref. | Ref. |
| 21–50 | 4.58 (1.40–15.01; 0.01) | 2.58 (0.59–11.26; 0.21) |
| 51–100 | 6.50 (1.71–24.68; 0.01) | 2.43 (0.45–13.19; 0.31) |
| > 100 | 2.19 (0.47–10.21; 0.32) | 1.00 (0.17–5.79; 1.00) |
Respondents not familiar with the DHFA were not shown the statements and are therefore excluded in this table
Multivariable logistic regression analysis of participation degree (< 80% of the patients registered versus > 80% of the patients registered), including factors with univariable p < 0.10
| Univariable | Multivariable | |
|---|---|---|
| Data obtained from the DHFA offers external parties (health insurers, National Health Care Institute) insight into the actual quality of hip fracture care. | 3.19 (1.14–8.95; 0.03) | 3.19 (1.14–8.95; 0.03) |
| I am confident that the DHFA working group makes a proper assessment what data (quality indicators) can be made available to external parties. | 2.68 (0.95–7.52; 0.06) | 1.55 (0.48–5.06; 0.47) |
| The added value of the DHFA is not clear. | 0.34 (0.12–0.96; 0.04) | 0.44 (0.15–1.28; 0.13) |
Respondents not familiar with the DHFA have not been shown the statements and are therefore excluded in this
| Domains | Questions | |
|---|---|---|
| 1. Knowledge | 1.1 Audit—general | - Are you familiar with clinical auditing? - What do you know about clinical auditing (do you believe it is evidence-based)? - Do you believe that auditing is a good tool for measuring/enhancing the quality of care? - Does your hospital already participate in any audit? ➔ If yes, what are the experiences? ➔ If not, why not? |
| 1.2 DHFA—specific | - Will a hip fracture audit make a useful contribution to hip fracture care? - Is this supported by the outcomes of existing hip fracture audits? - Are you familiar with the DHFA? ➔ If yes, what is the goal of the DHFA? How did you gain this knowledge? ➔ If not, are you a member of a professional association? Did you receive information about the DHFA from this association? | |
| 2. Skills | - Could you please explain how data is recorded in the DHFA? - Is this a reason for recording/not recording data? - Why? | |
| 3 Social/professional role and identity | 3.1 Current | - How is hip fracture care organised at your hospital? Are care trajectories in place? - How is the cooperation with geriatrics set up? - Who delivers care at your department? Specialist, resident, nurse? - Do you work according to quality indicators/guidelines? - How does this impact on your participation in the DHFA? |
| 3.2 Future | - Will the DHFA affect hip fracture care at your hospital? - How would the outcomes affect your working method? | |
| 4. Beliefs about capabilities | 4.1 Setup | - Did you manage to enter data into the DHFA? ➔ If yes, how did you go about this? ➔ If not, why not? - Would it be helpful if data entry/participation were simplified? - What action should be taken to enable participation in the DHFA? |
| 4.2 Continuation | - What action should be taken or has been taken to secure continued participation in the DHFA? - What action should be taken to promote more active participation in the DHFA? Why has such action not been taken so far? | |
| 5. Beliefs about consequences | 5.1 Quality | - Do you expect the DHFA to contribute to higher-quality hip fracture care? - How will the DHFA affect the quality of hip fracture care? |
| 5.2 Costs | - What is the ultimate effect of the DHFA on costs? | |
| 5.3 Influence | - What do you expect to be the outcomes of the DHFA for patients, professionals and hospitals? | |
| 6. Motivation and goals | 6.1 Motivation | - Is the DHFA needed to measure quality? - Are alternatives available to enhance the quality of hip fracture care? |
| 6.2 Facilitators/barriers | - What are the facilitators of participation in the DHFA? - What are the reasons for refusing to participate in the DHFA or discontinuing participation? | |
| 7. Memory, attention and decision process | 7.1 Own decision | - Given the current hospital-specific context, is it feasible for you to take part in the DHFA? ➔If yes, how did you secure this? ➔If not, what should change to make participation feasible? |
| 7.2 Parties involved | - What persons at your hospital are involved in the decision whether or not to participate in the DHFA? - How do they influence the decision-making process? - If they are not in favour of participation, what has been done or should be done to secure their support for participation in the DHFA? | |
| 8 Environmental context and resources | 8.1 Organisation | - To what extent do environmental factors (nationwide, regional, executive, organisational level) have an impact on participation or non-participation in the DHFA? - How does the multidisciplinary nature of the DHFA influence the participation? - What considerations may lead to participation or non-participation? |
| 8.2 Time | - How much time do you expect to be needed to participate in the DHFA? - Will this influence your decision whether or not to participate in the DHFA? | |
| 8.3 Financial | - What costs will be involved in initiating/continuing the DHFA? - Will financial considerations influence your decision as to participation in the DHFA? - How does this impact on your participation in the DHFA? | |
| 9. Social influences | 9.1 Professionals | - Do professionals of the same medical specialty (partnership/regional/nationwide) influence participation? - Do professionals of a different medical specialty (e.g. surgery, orthopaedics, internal medicine, geriatrics) influence participation? |
| 9.2 Patients | - Does the patient category influence the decision whether or not participate in the DHFA? | |
| 10. Emotion | - What consequences may the outcomes of the DHFA have? - How does this impact on your participation in the DHFA? - What action should be taken to remove or encourage these factors? - Can the outcomes be used to identify underperformers? And does this influence your participation? | |
| 11. Behavioural regulation | 11.1 Personal | - What should be done on both personal and organisational levels to enable participation in the DHFA? - How can the introduction of the DHFA be supported on both personal and organisational levels? |
| 11.2 Organisational | - What would the consequences be if recording data in the DHFA were made compulsory? - What is your opinion as quality assessment is based on quality indicators emerging from the DHFA? | |
| 12. Nature of the behaviours | 12.1 Current action | - Who is supposed to do what and when to enable participation in the DHFA? - How long will it take until all persons know what is expected from? |
| 12.2 Future action | - How can the implementation within hospitals be speeded up? - How can be secured that all parties involved stay motivated to participate? | |
| Coder 2 | ||||
|---|---|---|---|---|
| Identified | Not identified | |||
| Coder 1 | Identified | 47 | 1 | 48 |
| Not identified | 2 | 0 | 2 | |
| 49 | 1 | 50 | ||
Chance frequency cell A = (49 × 48)/50 = 47.04
Chance frequency cell D = (1 × 2)/50 = 0.04
Chance agreement = (47.04 + 0.04)/100 = 0.47
Chance corrected observed agreement = (47/50) − 0.47 = 0.47 (47%)
Chance corrected potential agreement = 100% − chance agreement (0.47) = 0.53 (53%)
Cohen’s kappa = (% chance corrected observed agreement/% chance corrected potential agreement) 47%/53% = 0.89